Challenging treatment of bilateral multiple infection panuveitis in HIV/AIDS patients
Journal Title: International Journal of Ophthalmology - Year 2018, Vol 11, Issue 6
Abstract
Letter to the Editor
Authors and Affiliations
Widya Artini
Keywords
Related Articles
- EP ID EP484269
- DOI 10.18240/ijo.2018.06.28
- Views 60
- Downloads 0
Metalloproteinases as mediators of inflammation and the eyes: molecular genetic underpinnings governing ocular pathophysiology
There are many vision threatening diseases of the eye affecting millions of people worldwide. In this article, we are summarizing potential role of various matrix metalloproteinases (MMPs); the Zn (2+)-dependent endoprot...
The process of retinal vascularization in retinopathy of prematurity after ranibizumab treatment in China
"AIM: To explore the process of retinal vascularization and risk factors for retinopathy of prematurity (ROP) treated with intravitreal ranibizumab (IVR) as monotherapy. METHODS: Infants with type 1 ROP who received IVR...
Down-regulation of protein kinase C alpha/ezrin signals in light-induced phagocytic crisis of retinal pigment epithelium cells
"AIM: To investigate the roles of PKC-α/ezrin signals in phagocytosis crisis of retinal pigment epithelium (RPE) cells in light damage model. METHODS: Light induced mice RPE injury model was established by continuously i...
Association of the macrophage migration inhibitory factor promoter polymorphisms with benign lymphoepithelial lesion of lacrimal gland
"AIM: To identify the association of the macrophage migration inhibitory factor (MIF) gene polymorphism with the susceptibility of benign lymphoepithelial lesions (BLEL) of the lacrimal gland. METHODS: A total of 40 BLEL...
Intraocular pressure with rebound tonometry and effects of topical intraocular pressure reducing medications in guinea pigs
"AIM: To investigate the intraocular pressure (IOP) of adult guinea pig eyes with rebound tonometry (RBT), and assess the effects of four distinctive topical IOP reducing medications including Carteolol, Brimonidine, Bri...